Bulletin
Investor Alert

New York Markets Close in:

Annovis Bio Inc.

ASE: ANVS

GO
/marketstate/country/us

Market open

 --Real time quotes

Oct 19, 2021, 1:22 p.m.

/zigman2/quotes/216213707/composite

$

29.27

Change

+0.07 +0.24%

Volume

Volume 73,395

Real time quotes

/zigman2/quotes/216213707/composite

Previous close

$ 29.20

$ 29.27

Change

+0.07 +0.24%

Day low

Day high

$28.82

$29.73

Open

52 week low

52 week high

$4.14

$132.00

Open

Insider Actions for Annovis Bio Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/12/2021 Mark White
Director
5,000   Acquisition at $27.4 per share. 137,000
10/11/2021 Maria-Luisa Maccecchini
PRESIDENT AND CEO; Director
18,000   Acquisition at $27.61 per share. 496,980
10/11/2021 Claudine E. Bruck
Director
181   Acquisition at $27.66 per share. 5,006
08/19/2021 Reid S. McCarthy
Director
500   Acquisition at $37.61 per share. 18,805
02/03/2020 Jeffrey B. McGroarty
Chief Financial Officer
164   Acquisition at $7.17 per share. 1,175
02/03/2020 Jeffrey B. McGroarty
Chief Financial Officer
19,336   Acquisition at $7.15 per share. 138,252
01/31/2020 Michael B. Hoffman
Director
55,884   Derivative/Non-derivative trans. at $4.8 per share. 268,243
01/31/2020 Michael B. Hoffman
Director
1,137,942   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Michael B. Hoffman
Director
158,730   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Maria-Luisa Maccecchini
PRESIDENT AND CEO; Director
762,896   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Maria-Luisa Maccecchini
PRESIDENT AND CEO; Director
7,937   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Robert M. Whelan
Director
11,176   Derivative/Non-derivative trans. at $4.8 per share. 53,644
01/31/2020 Robert M. Whelan
Director
59,524   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Mark White
Director
3,252   Derivative/Non-derivative trans. at $4.8 per share. 15,609
01/31/2020 Mark White
Director
34,643   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Mark White
Director
11,548   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Claudine E. Bruck
Director
1,117   Derivative/Non-derivative trans. at $4.8 per share. 5,361
01/31/2020 Claudine E. Bruck
Director
3,969   Derivative/Non-derivative trans. at $0 per share. 0
01/31/2020 Michael B. Hoffman
Director
33,333   Acquisition at $6 per share. 199,998
01/31/2020 Maria-Luisa Maccecchini
PRESIDENT AND CEO; Director
1,600   Acquisition at $6 per share. 9,600
01/31/2020 Robert M. Whelan
Director
25,000   Acquisition at $6 per share. 150,000
01/31/2020 Mark White
Director
1,734   Acquisition at $6 per share. 10,404
01/31/2020 Jeffrey B. McGroarty
Chief Financial Officer
33,333   Acquisition at $6 per share. 199,998
01/31/2020 Claudine E. Bruck
Director
800   Acquisition at $6 per share. 4,800

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
4 Purchases
0 Sales
23,681
0
Last 6 months
4 Purchases
0 Sales
23,681
0
Last 12 months
4 Purchases
0 Sales
23,681
0

Officers and Executives

Dr. Maria-Luisa Maccecchini
President, Chief Executive Officer & Director
Mr. Jeffrey B. McGroarty
Chief Financial Officer
Ms. Cheng Fang
Vice President-Research
Mr. Michael B. Hoffman
Chairman
Mr. Reid S. McCarthy
Independent Director
Dr. Claudine E. Bruck
Independent Director
Mr. Mark White
Independent Director
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.